Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma

31Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

The patient was a 70-year-old man with a recurrent pituitary tumor. Three surgeries were performed but the tumor recurred. Based on histologic, immunohistochemical and ultrastructural studies, the diagnosis of oncocytic gonadotrophic pituitary adenoma was made. The tumor was a macroadenoma partly immunopositive for LH. Immunohistochemistry for O6 Methylguanine-DNA Methyl-Transferase (MGMT) showed an admixture of immunopositive and immunonegative cells. After recurrence following operations, the patient was treated with Temozolomide, an imidazotetrazine derivative, DNA-alkylating drug. Following Temozolomide administration the MRI demonstrated significant tumor necrosis. A few months later, the patient died of massive pulmonary embolism. No autopsy was performed. The present case indicates that benign, typically slow-growing pituitary adenomas of oncocytic gonadotrophic type may respond to Temozolomide even when the tumor consists of an admixture of MGMT immunopositive and immunonegative cells.

References Powered by Scopus

MGMT gene silencing and benefit from temozolomide in glioblastoma

6100Citations
N/AReaders
Get full text

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1995Citations
N/AReaders
Get full text

Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide

745Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Aggressive pituitary tumors

145Citations
N/AReaders
Get full text

Aggressive pituitary tumours: The role of temozolomide and the assessment of MGMT status

142Citations
N/AReaders
Get full text

Treatment of pituitary neoplasms with temozolomide

92Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Syro, L. V., Scheithauer, B. W., Ortiz, L. D., Fadul, C. E., Horvath, E., Rotondo, F., & Kovacs, K. (2009). Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma. Hormones, 8(4), 303–306. https://doi.org/10.14310/horm.2002.1247

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

38%

Researcher 3

38%

Professor / Associate Prof. 2

25%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

80%

Engineering 1

10%

Chemistry 1

10%

Save time finding and organizing research with Mendeley

Sign up for free